vs
Side-by-side financial comparison of AMERICAN SUPERCONDUCTOR CORP (AMSC) and Vericel Corp (VCEL). Click either name above to swap in a different company.
Vericel Corp is the larger business by last-quarter revenue ($92.9M vs $74.5M, roughly 1.2× AMERICAN SUPERCONDUCTOR CORP). AMERICAN SUPERCONDUCTOR CORP runs the higher net margin — 158.1% vs 25.0%, a 133.1% gap on every dollar of revenue. On growth, Vericel Corp posted the faster year-over-year revenue change (23.3% vs 21.4%). Vericel Corp produced more free cash flow last quarter ($12.8M vs $2.4M). Over the past eight quarters, Vericel Corp's revenue compounded faster (34.6% CAGR vs 33.2%).
Anglo American plc is a British multinational mining company with headquarters in London, England. It is the world's largest producer of platinum, representing approximately 40 percent of global output, as well as being a major producer of diamonds, copper, nickel, iron ore, polyhalite and steelmaking coal. The company has operations in Africa, Asia, Australia, Europe, North America and South America.
Vericel Corporation is a publicly traded American biopharmaceutical company which was known prior to October 2014 as Aastrom Bio. Aastrom Bio was formed in 1989 in Ann Arbor, Michigan.
AMSC vs VCEL — Head-to-Head
Income Statement — Q3 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $74.5M | $92.9M |
| Net Profit | $117.8M | $23.2M |
| Gross Margin | 30.7% | 78.7% |
| Operating Margin | 4.5% | 24.1% |
| Net Margin | 158.1% | 25.0% |
| Revenue YoY | 21.4% | 23.3% |
| Net Profit YoY | 4679.1% | 17.3% |
| EPS (diluted) | $2.62 | $0.46 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $74.5M | $92.9M | ||
| Q3 25 | $65.9M | $67.5M | ||
| Q2 25 | $72.4M | $63.2M | ||
| Q1 25 | $66.7M | $52.6M | ||
| Q4 24 | $61.4M | $75.4M | ||
| Q3 24 | $54.5M | $57.9M | ||
| Q2 24 | $40.3M | $52.7M | ||
| Q1 24 | $42.0M | $51.3M |
| Q4 25 | $117.8M | $23.2M | ||
| Q3 25 | $4.8M | $5.1M | ||
| Q2 25 | $6.7M | $-553.0K | ||
| Q1 25 | $1.2M | $-11.2M | ||
| Q4 24 | $2.5M | $19.8M | ||
| Q3 24 | $4.9M | $-901.0K | ||
| Q2 24 | $-2.5M | $-4.7M | ||
| Q1 24 | $-1.6M | $-3.9M |
| Q4 25 | 30.7% | 78.7% | ||
| Q3 25 | 31.0% | 73.5% | ||
| Q2 25 | 33.8% | 73.7% | ||
| Q1 25 | 26.5% | 69.0% | ||
| Q4 24 | 26.6% | 77.6% | ||
| Q3 24 | 28.7% | 71.9% | ||
| Q2 24 | 30.3% | 69.5% | ||
| Q1 24 | 24.8% | 68.9% |
| Q4 25 | 4.5% | 24.1% | ||
| Q3 25 | 4.5% | 5.1% | ||
| Q2 25 | 7.8% | -3.2% | ||
| Q1 25 | 2.5% | -24.3% | ||
| Q4 24 | 2.1% | 24.5% | ||
| Q3 24 | -1.4% | -4.3% | ||
| Q2 24 | -8.2% | -11.5% | ||
| Q1 24 | -5.3% | -10.7% |
| Q4 25 | 158.1% | 25.0% | ||
| Q3 25 | 7.2% | 7.5% | ||
| Q2 25 | 9.3% | -0.9% | ||
| Q1 25 | 1.8% | -21.4% | ||
| Q4 24 | 4.0% | 26.3% | ||
| Q3 24 | 9.0% | -1.6% | ||
| Q2 24 | -6.3% | -8.9% | ||
| Q1 24 | -3.8% | -7.5% |
| Q4 25 | $2.62 | $0.46 | ||
| Q3 25 | $0.11 | $0.10 | ||
| Q2 25 | $0.17 | $-0.01 | ||
| Q1 25 | $0.04 | $-0.23 | ||
| Q4 24 | $0.06 | $0.40 | ||
| Q3 24 | $0.13 | $-0.02 | ||
| Q2 24 | $-0.07 | $-0.10 | ||
| Q1 24 | $-0.03 | $-0.08 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $141.1M | $137.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $536.8M | $354.6M |
| Total Assets | $719.5M | $488.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $141.1M | $137.5M | ||
| Q3 25 | $212.9M | $135.4M | ||
| Q2 25 | $207.9M | $116.9M | ||
| Q1 25 | $79.5M | $112.9M | ||
| Q4 24 | $75.2M | $116.2M | ||
| Q3 24 | $72.1M | $101.7M | ||
| Q2 24 | $93.5M | $102.5M | ||
| Q1 24 | $90.5M | $110.6M |
| Q4 25 | $536.8M | $354.6M | ||
| Q3 25 | $342.2M | $321.9M | ||
| Q2 25 | $333.1M | $306.8M | ||
| Q1 25 | $197.1M | $295.5M | ||
| Q4 24 | $192.7M | $292.0M | ||
| Q3 24 | $187.0M | $257.5M | ||
| Q2 24 | $143.3M | $243.0M | ||
| Q1 24 | $144.6M | $233.9M |
| Q4 25 | $719.5M | $488.0M | ||
| Q3 25 | $445.6M | $453.3M | ||
| Q2 25 | $452.8M | $435.6M | ||
| Q1 25 | $310.5M | $424.6M | ||
| Q4 24 | $310.3M | $432.7M | ||
| Q3 24 | $298.4M | $390.4M | ||
| Q2 24 | $240.1M | $376.8M | ||
| Q1 24 | $232.8M | $356.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $3.2M | $15.0M |
| Free Cash FlowOCF − Capex | $2.4M | $12.8M |
| FCF MarginFCF / Revenue | 3.2% | 13.8% |
| Capex IntensityCapex / Revenue | 1.2% | 2.4% |
| Cash ConversionOCF / Net Profit | 0.03× | 0.65× |
| TTM Free Cash FlowTrailing 4 quarters | $16.0M | $24.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $3.2M | $15.0M | ||
| Q3 25 | $6.5M | $22.1M | ||
| Q2 25 | $4.1M | $8.2M | ||
| Q1 25 | $6.3M | $6.6M | ||
| Q4 24 | $5.9M | $22.2M | ||
| Q3 24 | $12.7M | $10.2M | ||
| Q2 24 | $3.4M | $18.5M | ||
| Q1 24 | $2.2M | $7.2M |
| Q4 25 | $2.4M | $12.8M | ||
| Q3 25 | $5.1M | $19.5M | ||
| Q2 25 | $3.3M | $81.0K | ||
| Q1 25 | $5.3M | $-7.6M | ||
| Q4 24 | $5.3M | $8.5M | ||
| Q3 24 | $12.1M | $-9.2M | ||
| Q2 24 | $3.1M | $1.8M | ||
| Q1 24 | $1.9M | $-6.8M |
| Q4 25 | 3.2% | 13.8% | ||
| Q3 25 | 7.7% | 28.8% | ||
| Q2 25 | 4.6% | 0.1% | ||
| Q1 25 | 7.9% | -14.5% | ||
| Q4 24 | 8.7% | 11.2% | ||
| Q3 24 | 22.3% | -15.9% | ||
| Q2 24 | 7.8% | 3.4% | ||
| Q1 24 | 4.6% | -13.3% |
| Q4 25 | 1.2% | 2.4% | ||
| Q3 25 | 2.1% | 3.9% | ||
| Q2 25 | 1.1% | 12.9% | ||
| Q1 25 | 1.6% | 27.0% | ||
| Q4 24 | 0.9% | 18.3% | ||
| Q3 24 | 1.1% | 33.5% | ||
| Q2 24 | 0.7% | 31.8% | ||
| Q1 24 | 0.7% | 27.3% |
| Q4 25 | 0.03× | 0.65× | ||
| Q3 25 | 1.37× | 4.35× | ||
| Q2 25 | 0.61× | — | ||
| Q1 25 | 5.22× | — | ||
| Q4 24 | 2.38× | 1.12× | ||
| Q3 24 | 2.60× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AMSC
| Equipment And Systems | $56.0M | 75% |
| Megatran | $14.1M | 19% |
| Comtrafo Industria De Transformadores Eletricos SA | $4.6M | 6% |
VCEL
| MACI Implants And Kits | $84.1M | 90% |
| Other | $8.8M | 10% |
